Predictive Oncology Inc. (POAI) DCF Valuation

Predictive Oncology Inc. (POAI) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Predictive Oncology Inc. (POAI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (POAI) DCF Calculator empowers you to evaluate Predictive Oncology Inc. valuation using real-world financial data, along with complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1.4 1.3 1.4 1.5 1.8 1.9 2.0 2.2 2.3 2.4
Revenue Growth, % 0 -11.28 13.45 5.97 18.24 6.59 6.59 6.59 6.59 6.59
EBITDA -12.4 -11.5 -12.1 -14.0 -13.2 -1.9 -2.0 -2.2 -2.3 -2.4
EBITDA, % -879.38 -915.03 -853.91 -926.94 -740.52 -100 -100 -100 -100 -100
Depreciation .7 1.0 1.3 1.3 .7 1.3 1.4 1.5 1.6 1.7
Depreciation, % 49.94 81.84 94.34 87.22 41.53 70.97 70.97 70.97 70.97 70.97
EBIT -13.1 -12.5 -13.5 -15.3 -13.9 -1.9 -2.0 -2.2 -2.3 -2.4
EBIT, % -929.31 -996.87 -948.25 -1014.16 -782.06 -100 -100 -100 -100 -100
Total Cash .2 .7 28.2 22.1 8.7 1.4 1.5 1.6 1.7 1.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .3 .3 .4 .3 .3
Account Receivables, % 21.04 20.51 24.93 22 18.75
Inventories .2 .3 .4 .4 .5 .5 .5 .5 .6 .6
Inventories, % 13.47 23.12 27.29 28.6 27.77 24.05 24.05 24.05 24.05 24.05
Accounts Payable 3.2 1.4 1.0 .9 1.3 1.6 1.7 1.8 1.9 2.0
Accounts Payable, % 223.56 109.57 71.92 62.67 75.39 82 82 82 82 82
Capital Expenditure .0 -.4 -1.0 -.5 -.3 -.6 -.6 -.6 -.7 -.7
Capital Expenditure, % -1.88 -28.81 -67.74 -31.6 -16.99 -29.4 -29.4 -29.4 -29.4 -29.4
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -18.6 -18.2 -13.0 -21.5 -13.9 -1.9 -2.0 -2.1 -2.3 -2.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.3 -19.4 -13.2 -20.7 -13.2 -.9 -1.1 -1.2 -1.3 -1.4
WACC, % 7.59 7.59 7.53 7.59 7.59 7.58 7.58 7.58 7.58 7.58
PV UFCF
SUM PV UFCF -4.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -25
Present Terminal Value -17
Enterprise Value -22
Net Debt -6
Equity Value -16
Diluted Shares Outstanding, MM 4
Equity Value Per Share -4.00

What You Will Receive

  • Comprehensive Financial Model: Predictive Oncology Inc.'s actual data allows for accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Customizable Forecast Inputs: Adjust essential factors such as revenue projections, EBITDA margins, and research expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
  • High-Precision Accuracy: Leverages Predictive Oncology's real-world data for reliable valuation results.
  • Effortless Scenario Analysis: Easily explore various assumptions and evaluate different outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based POAI DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
  3. Instant Calculations: The model will automatically refresh Predictive Oncology's intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.

Why Choose This Calculator for Predictive Oncology Inc. (POAI)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your analytical needs.
  • Real-Time Feedback: Monitor immediate changes to Predictive Oncology’s valuation as you tweak inputs.
  • Preloaded Data: Comes with Predictive Oncology’s actual financial metrics for swift evaluation.
  • Relied Upon by Experts: Employed by investors and analysts for making data-driven decisions.

Who Should Use Predictive Oncology Inc. (POAI)?

  • Investors: Gain insights into the oncology market with advanced predictive analytics tools.
  • Healthcare Analysts: Streamline your research with comprehensive data models tailored for oncology.
  • Consultants: Easily customize reports and presentations for clients in the healthcare sector.
  • Oncology Researchers: Enhance your studies with real-time data and predictive outcomes.
  • Educators and Students: Utilize it as a resource for practical applications in healthcare analytics courses.

What the Template Contains

  • Preloaded POAI Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.